RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)

Clinical trials for RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML) explained in plain language.

Never miss a new study

Get alerted when new RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML) trials appear

Sign up with your email to follow new studies for RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Terminated 1

Experimental drug aims to tame tough blood cancers

Disease control Terminated

This study tested a new drug called S227928, both by itself and combined with an existing drug (venetoclax), for people with advanced forms of leukemia and related blood cancers that had stopped responding to standard treatments. The main goals were to find a safe and effective d…

Matched conditions: RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)

Phase: PHASE1, PHASE2 • Sponsor: Servier Bio-Innovation LLC • Aim: Disease control

Last updated Mar 09, 2026 14:23 UTC

RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)

Get alerted when new RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML) trials appear

Experimental drug aims to tame tough blood cancers